Dutasteride vs Finasteride for Hair Regrowth and Miniaturization: 2024 Systematic Review Research Summary
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in Dermatology Reports, 2024
Dutasteride vs Finasteride for Hair Regrowth and Miniaturization
Study conclusion
Systematic review comparing dutasteride and finasteride for pattern hair loss. Dutasteride showed superior efficacy in most included studies due to dual DHT enzyme blockade. However, no clear high-quality evidence was found to definitively support dutasteride in male AGA. Both drugs showed similar side effect profiles.
Strength of evidence
This was a narrative systematic review — it summarises findings without performing statistical pooling. The score is limited because no meta-analysis was conducted, evidence quality was assessed as variable, and the conclusion that there is no clear high-quality evidence for dutasteride in male AGA contrasts with other more recent meta-analyses. The review's conservative stance reflects strict evidence standards.
Who it applies to
Who was studied
Men and women with androgenetic alopecia. Studies of oral finasteride and dutasteride at any dose included. Searched through November 2022.
Who was NOT studied
People using topical versions of either drug. People with hair loss types other than androgenetic alopecia.
What to look for when shopping
Finasteride 1mg is FDA-approved for male pattern hair loss. Dutasteride is not FDA-approved for hair loss in the US. Both are prescription-only.
What research cannot help you decide
Whether dutasteride is safer than finasteride for female pattern hair loss. The review concludes evidence is still debated for women.
Key findings
- Dutasteride showed superior efficacy to finasteride in most individual studies due to blocking both Type 1 and Type 2 5-alpha-reductase enzymes
- This review found no clear high-quality evidence to definitively support dutasteride in male androgenetic alopecia
- For female pattern hair loss, the effectiveness of both drugs is still debated
- Women experienced improvement in hair thickness with both finasteride and dutasteride
- Side effect profiles were similar between the two drugs
What they did
Researchers searched multiple databases through November 2022 for studies comparing dutasteride and finasteride for pattern hair loss in men and women. Included studies of any design comparing the two drugs or reporting results for either drug in AGA. A narrative review approach was used without statistical pooling.
What they found
| Comparison | Result | Significant? |
|---|---|---|
| Dutasteride vs finasteride — efficacy in most included studies | Dutasteride superior in most studies | No |
| Dutasteride — high-quality evidence in male AGA | No clear high-quality evidence found by this review | No |
| Finasteride vs dutasteride — side effects | Similar profiles between drugs | No |
| Both drugs in female AGA — hair thickness | Improvement reported with both | Yes |
What this study does not show
- 1.Whether dutasteride is definitively superior in a large well-powered RCT — this review found no such evidence existed at time of search.
- 2.Long-term safety differences between the two drugs beyond available study periods.
- 3.Whether results in one sex apply to the other.
Limitations
- 1.Narrative review with no statistical pooling — cannot determine overall effect sizes
- 2.Searched only through November 2022 — more recent trials not included
- 3.Evidence quality was variable across included studies
- 4.Dutasteride is not FDA-approved for hair loss in the US
Who funded it
No funding source was declared. No conflicts of interest were reported.
Used in these articles
Links added as fact-checks and articles citing this study are published.